Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	Anti-von willebrand factor nanobody	Von Willebrand Factor Human	-	-	-	1件: 64 💬
2	Anti-von willebrand factor nanobody, caplacizumab	Caplacizumab	1件: D11160 💬	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation	1件: 64 💬
3	Anti-von willebrand factor nanobody, inn = caplacizumab	Caplacizumab	1件: D11160 💬	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation	1件: 64 💬
4	Caplacizumab (an anti-von willebrand factor nanobody alx-0081)	Caplacizumab	1件: D11160 💬	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation	1件: 64 💬
5	Caplacizumab (an anti-von willebrand factor nanobody)	Caplacizumab	1件: D11160 💬	1件: VWF 💬	8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation	1件: 64 💬